It’s been another tough few weeks for pharma employees as four more companies handed out pink slips in an effort to trim bottom lines.
Elan cut 14 percent of its global work force last Wednesday as a part of an ongoing strategic review process. The company announced that it would postpone biologics manufacturing, redesign R&D in [...]
Pharma Layoffs Continue